Komori
Zacros (7917) · InitiativeRestated

Developing New Technologies and Products Through the Integration of Technologies

First written in FY2016. 23 of 32 entries say "Restated". Latest entry: FY2026-H1.

32entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018-Q32016: 220162017: 420172018: 420182019: 220192020: 420202021: 420212022: 420222023: 320232024: 320242025: 22025
Same theme, other companies
Strengthening New Product and Technology Development Capabilities Through R&D and Basic ResearchA theme 218 companies write about · 0 as a headwind · 230 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 230 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「The Group’s total R&D expenses for the interim consolidated period were ¥2,133 million. There were no significant changes in the status of the Group’s R&D activities during the interim consolidated period.」

    The company reaffirmed that there had been no significant changes in the status of its R&D activities and disclosed interim-period R&D expenses of ¥2,133 million.
  2. FY2025AdvancedAnnual report

    「To further accelerate these activities, we are actively using digital technologies, including AI, MI (materials informatics), and various simulations, to improve the efficiency and reduce the labor intensity of the development process. Total R&D expenses for the consolidated fiscal year were ¥4,735 million, up 6.8% year on year.」

    Expanded the R&D toolkit to include AI, MI, and simulations, based on technology combinations, increasing R&D expenses to ¥4,735 million.
  3. FY2025-H1RestatedAnnual report

    「The Group’s total R&D expenses for the interim consolidated period were ¥2,513 million. There were no significant changes in the status of the Group’s R&D activities during the interim consolidated period.」

    R&D expenses of ¥2,513 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  4. FY2024AdvancedAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥4,431 million, up 17.9% year on year.」

    Continued technology combinations and solution creation in 4 fields, increasing R&D expenses by 17.9% to ¥4,431 million.
  5. FY2024-Q3RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative third quarter period were ¥3,177 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative third quarter period.」

    R&D expenses of ¥3,177 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  6. FY2024-Q2RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative second quarter period were ¥2,084 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative second quarter period.」

    R&D expenses of ¥2,084 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  7. FY2024-Q1RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative first quarter period were ¥1,020 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative first quarter period.」

    R&D expenses of ¥1,020 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  8. FY2023AdvancedAnnual report

    「In the wellness, environmental solutions, information electronics, and construction and civil engineering materials fields, the Group is pursuing the development of new technologies and products that meet market needs through “technology combinations,” created by adding various solution technologies to its core technologies, including coating and laminating. Total R&D expenses for the consolidated fiscal year were ¥3,759 million, up 6.0% year on year.」

    Continued technology combinations in 4 fields, with R&D expenses of ¥3,759 million, up 6.0% year on year.
  9. FY2023-Q2RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative second quarter period were ¥1,803 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative second quarter period.」

    R&D expenses of ¥1,803 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  10. FY2023-Q1RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative first quarter period were ¥905 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative first quarter period.」

    R&D expenses of ¥905 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  11. FY2022AdvancedAnnual report

    「In the wellness, environmental solutions, information electronics, and construction and civil engineering materials fields, the Group is pursuing the development of new technologies and products that meet market needs through “technology combinations,” created by adding various solution technologies to its core technologies, including coating and laminating. Total R&D expenses for the consolidated fiscal year were ¥3,545 million, up 16.7% year on year.」

    The company outlined an R&D policy applying technology combinations to 4 fields. R&D expenses were ¥3,545 million, up 16.7% year on year.
  12. FY2022-Q3RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative third quarter period were ¥2,599 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative third quarter period.」

    R&D expenses of ¥2,599 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  13. FY2022-Q2RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative second quarter period were ¥1,675 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative second quarter period.」

    R&D expenses of ¥1,675 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  14. FY2022-Q1RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative first quarter period were ¥790 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative first quarter period.」

    R&D expenses of ¥790 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  15. FY2021AdvancedAnnual report

    「In the life sciences and information electronics fields, the Group is pursuing R&D activities to create new value through the development of new technologies and products that meet market needs, by adding various solution technologies to its core technologies, including coating and laminating, and thereby creating “technology combinations.” Total R&D expenses for the consolidated fiscal year were ¥3,038 million, up 2.0% year on year.」

    Continued R&D centered on technology combinations, with R&D expenses of ¥3,038 million, up 2.0% year on year.
  16. FY2021-Q3RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative third quarter period were ¥2,135 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative third quarter period.」

    R&D expenses of ¥2,135 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  17. FY2021-Q2RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative second quarter period were ¥1,388 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative second quarter period.」

    R&D expenses of ¥1,388 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  18. FY2021-Q1RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative first quarter period were ¥651 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative first quarter period.」

    R&D expenses of ¥651 million were recorded, and the company stated that there had been no significant changes in the status of its R&D activities.
  19. FY2020AdvancedAnnual report

    「In the life sciences and information electronics fields, the Group is pursuing R&D activities to create new value through the development of new technologies and products that meet market needs, by adding various solution technologies to its core technologies, including coating and laminating, and thereby creating “technology combinations.” Total R&D expenses for the consolidated fiscal year were ¥2,978 million, up 9.4% year on year.」

    Continued R&D based on technology combinations, with R&D expenses of ¥2,978 million, up 9.4% year on year.
  20. FY2020-Q3RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative third quarter period were ¥2,180 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative third quarter period.」

    R&D expenses of ¥2,180 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  21. FY2020-Q2RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative second quarter period were ¥1,435 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative second quarter period.」

    R&D expenses of ¥1,435 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  22. FY2019AdvancedAnnual report

    「As one of the foundations for these activities, we established an Innovation Center in August of the current fiscal year and began operating it as a research institute.」

    To create new businesses over the medium to long term, the company established an Innovation Center and began operating it as a research institute.
  23. FY2019-Q2RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative second quarter period were ¥1,340 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative second quarter period.」

    R&D expenses of ¥1,340 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  24. FY2019-Q1RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative first quarter period were ¥626 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative first quarter period.」

    R&D expenses of ¥626 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  25. FY2018AdvancedAnnual report

    「The Group is pursuing R&D activities to create new value through the development of new technologies and products that meet market needs, by adding various solution technologies to its core technologies, including coating and laminating, and thereby creating “technology combinations.” Total R&D expenses for the consolidated fiscal year were ¥2,775 million, up 6.0% year on year.」

    Continued R&D based on technology combinations, with R&D expenses of ¥2,775 million, up 6.0% year on year.
  26. FY2018-Q3RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative third quarter period were ¥2,069 million. There were no noteworthy changes in the status of the Group’s R&D activities during the cumulative third quarter period.」

    R&D expenses of ¥2,069 million were recorded, and the company reaffirmed that there had been no noteworthy changes in the status of its R&D activities.
  27. FY2018-Q2RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative second quarter period were ¥1,360 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative second quarter period.」

    R&D expenses of ¥1,360 million were recorded, and the company reaffirmed that there had been no significant changes in the status of its R&D activities.
  28. FY2018-Q1RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative first quarter period were ¥660 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative first quarter period.」

    R&D expenses of ¥660 million were recorded, while the company stated that there had been no significant changes in the status of its R&D activities.
  29. FY2017RestatedAnnual report

    「Total R&D expenses for the consolidated fiscal year were ¥2,619 million, up 5.2% year on year.」

    Continued R&D, including technology combinations and collaboration with external organizations, and recorded R&D expenses of ¥2,619 million.
  30. FY2017-Q3RestatedAnnual report

    「The Group’s total R&D expenses for the cumulative third quarter period were ¥1,964 million. There were no significant changes in the status of the Group’s R&D activities during the cumulative third quarter period.」

    R&D expenses of ¥1,964 million were recorded, and the company explicitly stated that there had been no significant changes in the status of its R&D activities.
  31. FY2017-Q2RestatedAnnual report

    「There were no significant changes in the status of the Group’s R&D activities during the cumulative second quarter period.」

    The company explicitly stated that there had been no significant changes in its R&D activities and reaffirmed its existing policy.
  32. FY2016First statedAnnual report

    「We are pursuing R&D activities to create new value through the development of new technologies and products that meet market needs, by adding various solution technologies to our core technologies, including coating and laminating, and thereby creating “technology combinations.”」

    Pursuing R&D that combines core technologies with solution technologies. R&D expenses were ¥2,488 million.
Moved together

"Strengthening Growth Drivers" moved the same way as this thread, in the same document, in 6 of its 32 moves.

665555★123456
  1. ★This thread
  2. 1Strengthening Growth Drivers6×
  3. 2Stable, Ongoing Dividends and Improving ROE6×
  4. 3Focus on efficiency5×
  5. 4Expansion of Overseas Production and Sales5×
  6. 5Demand Fluctuations in Electrical and Electronics-Related Markets5×
  7. 6Improving Operating Profit, Profit Margin and ROA5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Zacros's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.